[Drug reaction with eosinophilia and systemic symptoms (DRESS) following imatinib therapy].

Background: Imatinib (Gleevec) is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia. We describe a case of drug reaction with eosinophilia and systemic symptoms (DRESS) after institution of treatment with imatinib.

Patient And Methods: A 78-year-old woman was treated with low-dose imatinib for chronic myeloid leukemia since November 2003.